KIT and gastrointestinal stromal tumor: GIST is driven by genetic mutations with distinct signatures, with KIT mutations presenting in 60%–70% of cases and platelet‐derived growth factor receptor alpha (PDGFRA) in 10%–15%.5, 6, 7